Our Trustees

Dame Suzi Leather DBE, DL - Chair

Appointed to the Board: September 2023

Dame Suzi has been Chair of the OIA Board since October 2016. This role concludes on 30 September 2023. She has a wide professional background having been Chair of the Charity Commission, the Human Fertilisation and Embryology Authority, the School Food Trust, the School Meals Review Panel and the Council of Food Policy Advisers. She was the founder Deputy Chair of the UK Food Standards Agency and has also served on the Council and Ethics Committee of Exeter University.

In the health field she chaired the Integrated Care System for Devon, the Exeter and District Community NHS Trust and the Ethics Committee of the Royal College of Obstetricians and Gynaecologists. She has been a member of the Human Tissue Authority, an observer member of the Human Genetics Commission and sat on the steering group of the UK Stem Cell Bank.

More widely, she was a member of Consumer Focus and the United Kingdom Accreditation Service. She is a Patron of the UKCEN UK Clinical Ethics Network. She is a member of Pinhoe and Poltimore PCC and is Deputy Lieutenant of Devon.

Dame Suzi also has lived experience of dementia as both of her parents had dementia.

Professor Hugh P. McKenna CBE - Vice Chair

Appointed to the Board: September 2019

Hugh McKenna is a professor of nursing and until recently was Dean of Medical School Development and PVC Research and Innovation at Ulster University. He has over 250 publications, including 17 books; his latest on the societal impact of research. He was appointed Commander of the British Empire and is a Fellow of four prestigious organisations.

In 2013, he received an Outstanding Achievement Award from the Royal College of Nursing and in 2014, a lifetime achievement Award. In a 2018 UK Government report he was named one of the most influential nurses in the 70-year history of the NHS. In 2019, he was appointed Member of the Academia Europaea, and in 2020 a Member of the European Academy of Sciences and Arts.

He chairs the Study Steering Committee for a National Institute of Health Research on older persons’ oral hygiene in nursing homes. He sits on the DoH’s Clinical Ethics Forum, advising on ethical issues facing health and social care.

Until recently he was chair of the largest mental health, learning disability and addiction charity on the island of Ireland. In 2020, he was appointed Non-Executive Director of the Western Health & Social Care Trust and Auditor for the Hong Kong Quality Assurance Council. 

Susan Allen, OBE

Appointed to the Board: March 2021

Susan Allen has worked in financial services for more than 25 years and has extensive experience across retail and corporate banking, global banking, operations and strategic roles with a specific focus on transformation and business leadership.  

In January 2019, she was appointed CEO Retail and Business Banking sitting on the Executive Committee and Santander UK Board.  She is responsible for leadership of Santander’s retail contact centres, branches, provision of mortgages, wealth and private banking.  

Before joining Santander, Susan was the Chief Executive Officer, Customer Solutions Group, Commercial and Private Banking at RBS.  She is a champion of diversity and inclusivity and is the Executive Sponsor of the Santander LGBT network.  

She is also an active sponsor of Santander Returnships, Apprenticeships and Traineeships; all of which reflect her personal drive and commitment to enable a working environment that allows everyone to thrive.

Susan has direct experience of Alzheimer’s within her own family and is passionate about the role the society can play In supporting those living with dementia and all those who care for them.

Phil Andrew

Appointed to the Board: November 2023

Phil Andrew is Group Chief Executive at Orbit, one of the UK’s foremost housing groups.

Phil has more 30 years’ experience in leadership positions across the for-profit, governmental contracting and not-for-profit environments. The last 15 years specialising in commercially minded organisations that are driven by social purpose.

Prior to joining Orbit, Phil served as Chief Executive at StepChange Debt Charity and Chief Executive of Working Links. He has also held a number of senior positions in the UK and France including Chief Finance Officer of Sodexo UK & Ireland, and Chief Executive, Sodexo Justice Services. He is a Chartered Accountant, qualified treasurer, and Chartered Marketer, and was previously Vice-Chair of Raven Housing Trust and Chair of the Breck Foundation, an online safety awareness charity.

Sube Banerjee, MBE, FMedSci

Appointed to the Board: March 2021

Sube Banerjee MBE is Executive Dean of the Faculty of Health at the University of Plymouth and Professor of Dementia.  He trained at St Thomas’s Hospital, the London School of Hygiene and Tropical Medicine, the Institute of Psychiatry, and the London Business School.

Clinically he works as an old age psychiatrist and has focused on the development and delivery of high quality memory assessment services and post-diagnostic care.

He served as the Department of Health for England’s senior professional advisor on dementia and led the development and delivery of its National Dementia Strategy. He is active in clinical research and focusses on quality of life and quality of care in dementia and the evaluation of new treatments and services.

He works with governments and the WHO on health policy and strategies to improve health for older adults with complex needs and those with dementia.

Anthony Battle

Anthony Battle has worked in data, digital and technology for 25 years around the world within the energy, natural resources and automotive industries in both strategic and operational roles delivering transformational outcomes and sustainable change, in which he gained extensive experience across natural resources exploration, oil and gas operations, mining operations, manufacturing, supply chain and Business to Customer & Business to Business retail.

In March 2022, Anthony was appointed Group Chief Digital Information Officer at Jaguar Land Rover, with responsibility for leadership of the information & digital technology operations and transformation across design, engineering, industrial operations and retail, inclusive of architecture, cyber security, data, AI and automation.

Before joining Jaguar Land Rover, Anthony was the Chief Information Officer & Chief Technology Officer for Shell Energy, as a member of Executive Committee and Board of Directors, with responsibility for both Business to Customer and Business to Business areas in the UK and Europe.

Prior to Shell, Anthony occupied senior leadership roles in Anglo American and Eni; living and working in both Europe and the Caribbean.

Anthony is an ambassador of the JLR Graduate Innovation Challenge and a sponsor of the JLR Women in Digital community; reflecting his passion and commitment for diversity, inclusion and growth within the workplace. In addition, Anthony is a governing body co-chair of the Evanta UK & Ireland CIO community, helping digital leaders to share ideas, validate strategies and solve critical leadership challenges through peer-to-peer insight and collaboration.

Andy Boyle

Appointed to the Board: June 2025

Andy Doyle is the Chief People Officer at Kantar. He is a transformation specialist committed to improving business performance with experience developing strategy and driving cultural change.

Prior to joining Kantar, Andy was Chief People and Culture Officer for National Grid Plc, the UK and US-based electricity systems operator. In his role there, he focused on setting and delivering the global human resources agenda in line with the commercial strategy of the Group. Prior to National Grid he was CHRO and a member of the executive leadership team that successfully floated Worldpay and managed its subsequent merger with Vantiv Inc. Andy previously also led the HR function at broadcaster ITV plc and utility services and construction company Morrison plc.

Andy has held non-executive roles in different capacities for the last two decades. He was the former Chair of the Loughborough Student’s Union and a previous Governor and Chair of the Remuneration Committee at Middlesex University as well as a former Non-Executive Director at Fenwick.

Andy has personal experience with a number of family members having lived with dementia. He used the Alzheimer's Society services when helping them navigate their care and is passionate about ensuring there is a world in which dementia no longer devastates lives.

Caroline Fawcett

Appointed to the Board: March 2019

Caroline is an experienced Customer Experience Consultant and Non-Executive Director. She has served on Boards in both the financial services industry and the public sector. These included the Board of a leading NHS Trust that provides health and social care services for people with mental ill-health and learning disabilities.

She currently holds Non-Executive Director positions with Cambridge and Counties Bank and with LifeSight, the pension trustee for Willis Towers Watson’s master trust pension scheme.

Caroline has spent a large part of her career leading customer driven change programmes across a wide range of public and private sector organisations, increasing their focus on their customers and introducing cultural change to improve both customer and employee experiences. These included customer transformation programmes at the Care Quality Commission and Prudential Assurance.

Previously Caroline was Customer Experience Director at Legal & General, having spent over 25 years in marketing and customer experience roles in the financial services industry.

As well as her professional involvement with people with severe dementia while working with the NHS Trust, Caroline has direct experience of caring for her late mother who had both Alzheimer’s disease and vascular dementia. She had the opportunity to get to really understand the valuable work of the Alzheimer’s Society in both capacities.

Dr Malte Gerhold

Appointed to the Board: November 2023

Dr Malte Gerhold has held senior leadership roles in the public, private and third sector in health and social care, in the UK and abroad.

He is currently Director of Innovation and Improvement at the Health Foundation, a charitable foundation with the mission to improve health and health care in the UK. He is also a Director of THIS Labs, a start-up that uses large-scale, online collaborative approaches to enable successful improvement and innovation in health and care.

Previously, Malte was Chief Integrated Care Officer at Birdie, a digital care management start-up helping to reinvent care at home. Before that he was a Board member and Executive Director of Strategy and Intelligence at the Care Quality Commission. He has also lived and worked in Sierra Leone, and in the UK he worked at the Prime Minister’s Delivery Unit, the Department of Health, and Accenture. 

Anthony Lobo

Appointed to the Board: November 2023

Anthony is currently a Board member at KPMG in the UK, where he chairs the Audit Committee and is a member of the Risk Committee and Audit Board. He has been partner at KPMG for more than 16 years specialising in mergers and acquisitions across a variety of sectors, and acting as a global lead partner for one of the firms largest clients over the past 6 years. He has lived and worked in Africa, Asia and Europe during his career and has a wealth of experience in understanding and managing complex businesses.

Anthony qualified as a Chartered Accountant in London and is a member of the Institute of Chartered Accountants in England and Wales. He has direct experience of dementia through his late mother who developed Posterior cortical atrophy in her early 60’s.

Professor Paresh Malhotra

Appointed to the Board: June 2025

Professor Paresh Malhotra is Head of the Division of Neurology in the Department of Brain Sciences at Imperial College London and Honorary Consultant Neurologist at Imperial College Healthcare NHS Trust. He completed his medical training in Oxford and carried out a PhD at the University of London (Imperial and the UCL Institute of Cognitive Neuroscience).

He specialises in cognitive disorders and dementia. His clinical and research work focuses on developing and evaluating new diagnostic approaches and treatments for these diseases. He is actively involved in national and international research collaborations, including projects investigating hearing loss and dementia, and biomarker studies in the earliest stages of Alzheimer’s disease.

He is a member of the UK Dementia Research Institute and contributes to the ACORD initiative on innovative trials for dementia and neurodegeneration. At Imperial he is Clinical Academic Training lead for Neurology and co-chair of the Department of Brain Science’s Equality, Diversity and Inclusion Committee.

He has previously chaired the Association of British Neurologists Cognitive Neurology Special Interest Group and has been Deputy Chair of the Alzheimer’s Society Research Strategy Council.

His research has been supported by the Alzheimer’s Society, Alzheimer’s Research UK, NIHR, MRC, Lifearc and the Biomedical Research Centre at Imperial. He currently serves as the NIHR RDN National Specialty Lead for Dementia and Neurodegeneration and leads a work package in the UK Dementia Trials Accelerator.

His work has been featured in, and he has provided expert comment for, multiple media outlets including Sky News, ITV, the BBC, The Times, The Guardian, The Telegraph and The Mail as well as the wider international press.